Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF‐κB‐dependent transcriptional control of α2,3‐sialyltransferase I, II, and VI in human castration‐resistant prostate cancer cells
Authors:
Open Access
- 16 December 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 129 (8) , 1838-1847
Abstract
Gangliosides are sialic acid–containing glycosphingolipids that are associated with tumor malignancy and progression. Among the enzymes required for the production of gangliosides, sialyltransferases have received much attention in terms of their relationship with cancer. In our previous report, ganglioside GD1a and sialyl paragloboside (SPG), a neolacto‐series ganglioside, were much more abundant in PC3 and DU145 cells, castration‐resistant prostate cancer cells, as compared with hormone‐sensitive prostate cancer cells and normal prostate epithelium. GD1a is synthesized from GM1 by α2,3 sialyltransferase (ST3Gal) I and mainly by ST3Gal II. The enzyme to synthesize SPG is ST3Gal VI. The high production of GD1a and SPG in castration‐resistant prostate cancer cells was correlated with the high expression of ST3Gal II and VI, respectively. The expression of ST3Gal I and II was mildly induced by phorbol‐12‐myristate‐13‐acetate (PMA), and PMA‐induced expression of ST3Gal I and ST3Gal II was inhibited by NF‐κB decoy oligodeoxynucleotides (ODN) but not by AP‐1 decoy ODN. Among the five mammalian homologs of the NF‐κB family, RelB RNAi most effectively inhibited the expression of ST3Gal I and ST3Gal II. The expression of ST3Gal VI was also most effectively inhibited by RelB RNAi. The amount of GD1a and SPG was significantly reduced by RelB siRNA treatment in PC3 cells. Thus, the production of GD1a and SPG in castration‐resistant prostate cancer cells was indirectly controlled by NF‐κB, mainly by RelB, through the transcriptional regulation of ST3Gal I, II, and VI.Keywords
This publication has 45 references indexed in Scilit:
- Phosphoinositide 3-Kinase Pathway Activation in Phosphate and Tensin Homolog (PTEN)-deficient Prostate Cancer Cells Is Independent of Receptor Tyrosine Kinases and Mediated by the p110β and p110δ Catalytic SubunitsJournal of Biological Chemistry, 2010
- Oncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancerGene Therapy, 2010
- An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κBNature Medicine, 2010
- IKK/NF‐κB and STAT3 pathways: central signalling hubs in inflammation‐mediated tumour promotion and metastasisEMBO Reports, 2009
- Requirement for NF-κB signalling in a mouse model of lung adenocarcinomaNature, 2009
- ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell linesBMC Cancer, 2009
- RelB Enhances Prostate Cancer Growth: Implications for the Role of the Nuclear Factor-κB Alternative Pathway in TumorigenicityCancer Research, 2009
- NF‐κB p52:RelB heterodimer recognizes two classes of κB sites with two distinct modesEMBO Reports, 2008
- The Nuclear Factor-κB Pathway Controls the Progression of Prostate Cancer to Androgen-Independent GrowthCancer Research, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008